The FDA granted orphan drug designation to CTD402 for relapsed or refractory T-cell acute lymphoblastic leukemia and ...

PharmaEssentia Announces Updated NCCN Clinical Practice Guidelines Include ropeginterferon alfa-2b-njft (BESREMi®) for ...

Being a multiple myeloma care partner involves significant logistical and emotional challenges. Panelists acknowledge the ...

Dr. Anne Peled, a two-time breast cancer survivor, underwent a sensation-preserving mastectomy, a procedure she co-developed.

The FDA approved Darzalex Faspro with Velcade, Revlimid and dexamethasone for newly diagnosed multiple myeloma ineligible for ...

San Francisco-based surgeon Dr. Anne Peled, herself a two-time breast cancer survivor, sat down for an interview with CURE to ...

The trauma of the initial diagnosis triggers anxiety whenever the daughter calls, reflecting the lasting impact. If you’re ...

The FDA granted breakthrough therapy designation to bezuclastinib plus Sutent for patients with gastrointestinal stromal ...

Many childhood cancer survivors do not receive essential follow-up care, and researchers from the Keck School of Medicine of ...

A positive mindset and resilience are crucial in overcoming the challenges of a cancer diagnosis and can be cultivated ...

Sofetabart mipitecan received FDA breakthrough therapy designation for platinum-resistant ovarian cancer after prior ...

Low baseline ctDNA levels in advanced breast cancer patients predict better response to targeted therapy and longer ...